首页> 美国卫生研究院文献>Antimicrobial Agents and Chemotherapy >Treatment by Posaconazole Tablets Compared to Posaconazole Suspension Does Not Reduce Variability of Posaconazole Trough Concentrations

【2h】

Treatment by Posaconazole Tablets Compared to Posaconazole Suspension Does Not Reduce Variability of Posaconazole Trough Concentrations

机译：与泊沙康唑悬浮液相比泊沙康唑片治疗不会降低泊沙康唑谷浓度的变异性

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

期刊名称 Antimicrobial Agents and Chemotherapy
作者
Elodie Gautier-Veyret; Léa Bolcato; Matthieu Roustit; Stéphanie Weiss; Julia Tonini; Marie-Pierre Brenier-Pinchart; Muriel Cornet; Anne Thiebaut-Bertrand; Françoise Stanke-Labesque;
展开▼
作者单位

展开▼
年(卷),期 2019(63),10
年度 2019
页码 -1
总页数 8
原文格式 PDF
正文语种
中图分类药学;微生物学;
关键词
hematopoietic stem cell transplantation; posaconazole; therapeutic drug monitoring; trough concentration; variability;

机译：造血干细胞移植;泊沙康唑;治疗药物监测;谷浓度;变异性;

相似文献

外文文献
中文文献
专利

1. Treatment by Posaconazole Tablets, Compared to Posaconazole Suspension, Does Not Reduce Variability of Posaconazole Trough Concentrations [J] . Gautier-Veyret Elodie, Bolcato Lea, Roustit Matthieu, Antimicrobial agents and chemotherapy. . 2019,第10期

机译：与posaconazole悬浮液相比，posaconazole片剂的处理不会降低posaconazole槽浓度的可变性
2. Comparison of posaconazole serum concentrations from haematological cancer patients on posaconazole tablet and oral suspension for treatment and prevention of invasive fungal infections [J] . Pham Aaron N., Bubalo Joseph S., Lewis James S. II Mycoses: Diagnosis, therapy and prophylaxis of fungal diseases . 2016,第4期

机译：普沙康唑片和口服混悬液用于治疗和预防侵袭性真菌感染的血液癌症患者的泊沙康唑血清浓度比较
3. Tablets or oral suspension for posaconazole in lung transplant recipients? Consequences for trough concentrations of tacrolimus and everolimus [J] . Chanoine Sebastien, Gautier-Veyret Elodie, Pluchart Helene, British Journal of Clinical Pharmacology . 2021,第2期

机译：Posconazole在肺移植受者的片剂或口服悬浮液？ Tacrolimus和everolimus的槽浓度的后果
4. POSACONAZOLE PHARMACOKINETICS IN CATS AFTER ORAL AND IV ADMINISTRATION [C] . Dianne Mawby, Leanne Fowler, Mark Papich, Conference of the American^College^of^Veterinary^Internal^Medicine . 2016

机译：口服和IV管理后猫的posaconazole药代动力学
5. A Pilot Randomized Controlled Trial Comparing the Efficacy of Problem-Solving Therapy to Enhanced Treatment as Usual for Reducing High Blood Pressure [D] . Greenberg, Lauren Miriam 2015

机译：解决问题的疗法与通常用于降低高血压的强化治疗的疗效比较的试验性随机对照试验
6. Evaluation of Serum Posaconazole Concentrations in Patients with Hematological Malignancies Receiving Posaconazole Suspension Compared to the Delayed-Release Tablet Formulation [O] . Morgan Belling, Abraham S. Kanate, Alexandra Shillingburg, 2017

机译：与延迟释放片剂相比接受泊沙康唑悬浮液治疗的血液系统恶性肿瘤患者血清泊沙康唑浓度的评估
7. Superior Serum Concentrations with Posaconazole Delayed-Release Tablets Compared to Suspension Formulation in Hematological Malignancies [O] . Aaron Cumpston, Ryan Caddell, Alexandra Shillingburg, 2015

机译：优异的血清浓度与血清酰唑延迟释放片剂相比，与血液恶性恶性肿瘤中的悬浮制剂相比

Treatment by Posaconazole Tablets Compared to Posaconazole Suspension Does Not Reduce Variability of Posaconazole Trough Concentrations

著录项

相似文献

相关主题

期刊订阅